Please use this identifier to cite or link to this item: https://doi.org/10.1093/carcin/bgi093
DC FieldValue
dc.titleThe effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore
dc.contributor.authorCeschi, M.
dc.contributor.authorSun, C.-L.
dc.contributor.authorVan Den Berg, D.
dc.contributor.authorKoh, W.-P.
dc.contributor.authorYu, M.C.
dc.contributor.authorProbst-Hensch, N.
dc.date.accessioned2014-12-01T06:57:10Z
dc.date.available2014-12-01T06:57:10Z
dc.date.issued2005-08
dc.identifier.citationCeschi, M., Sun, C.-L., Van Den Berg, D., Koh, W.-P., Yu, M.C., Probst-Hensch, N. (2005-08). The effect of cyclin D1 (CCND1) G870A-polymorphism on breast cancer risk is modified by oxidative stress among Chinese women in Singapore. Carcinogenesis 26 (8) : 1457-1464. ScholarBank@NUS Repository. https://doi.org/10.1093/carcin/bgi093
dc.identifier.issn01433334
dc.identifier.urihttp://scholarbank.nus.edu.sg/handle/10635/113676
dc.description.abstractCyclin D1 (CCND1), an intracellular cell-cycle regulatory protein with checkpoint function, can promote cell proliferation or induce growth arrest and apoptosis depending on the cellular context. We hypothesized that the direction of the association between the (CCND1) G870A-polymorphism and breast cancer risk may be modified by dietary and genetic factors influencing the oxidant-antioxidant balance, such as a dietary pattern with a high intake of n-6 fatty acids and a low intake of n-3 fatty acids, or a genetic profile that is deficient in glutathione S-transferases. We tested our hypothesis in a case-control study nested into the Singapore Chinese Health Study, a prospective investigation of diet and cancer in 63 000 Chinese men and women. Genomic DNA collected from 258 incident cases of breast cancer and 670 female cohort controls was examined for CCND1, GSTM1, GSTT1 and GSTP1 genes using fluorogenic 5′-nuclease assay. Unconditional logistic regression models were used to assess the effects with adjustment for potential confounders. All statistical tests were two-sided. The heterozygous CCND1 GA genotype significantly reduced the breast cancer risk in all subjects (OR = 0.67, 95% CI 0.45-0.99) when compared with the GG genotype. The association was restricted to women with a high (above median value) intake level of n-6 fatty acids (OR = 0.51, 95% CI 0.30-0.87), a low (below median value) intake level of the antagonistic marine n-3 fatty acids (OR = 0.54, 95% CI 0.32-0.93) or a total lack of the antioxidative GSTM1 (OR = 0.44, 95% CI 0.25-0.80) or GSTT1 genes (OR = 0.46, 95% CI 0.24-0.87). The effects were consistently stronger in cases with advanced disease. The AA genotype did not affect breast cancer risk. The results of this study are compatible with the hypothesis that the oxidant-antioxidant balance in cells is an important determinant of the direction of the cyclin D1 effect, leading either to cell proliferation or cell death. © Oxford University Press 2005; All rights reserved.
dc.sourceScopus
dc.typeArticle
dc.contributor.departmentCOMMUNITY,OCCUPATIONAL & FAMILY MEDICINE
dc.description.doi10.1093/carcin/bgi093
dc.description.sourcetitleCarcinogenesis
dc.description.volume26
dc.description.issue8
dc.description.page1457-1464
dc.description.codenCRNGD
dc.identifier.isiut000230724700019
Appears in Collections:Staff Publications

Show simple item record
Files in This Item:
There are no files associated with this item.

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.